Barclays’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-7,699
| Closed | -$1.08M | – | 4558 |
|
|
2018
Q4 | $1.08M | Sell |
7,699
-18,093
| -70% | -$2.53M | ﹤0.01% | 1777 |
|
|
2018
Q3 | $4.41M | Buy |
25,792
+19,082
| +284% | +$3.26M | ﹤0.01% | 1147 |
|
|
2018
Q2 | $1.16M | Sell |
6,710
-2,617
| -28% | -$454K | ﹤0.01% | 1763 |
|
|
2018
Q1 | $1.08M | Buy |
9,327
+3,554
| +62% | +$410K | ﹤0.01% | 1754 |
|
|
2017
Q4 | $485K | Buy |
5,773
+3,108
| +117% | +$261K | ﹤0.01% | 2107 |
|
|
2017
Q3 | $246K | Buy |
2,665
+1,124
| +73% | +$104K | ﹤0.01% | 2288 |
|
|
2017
Q2 | $123K | Sell |
1,541
-3,372
| -69% | -$269K | ﹤0.01% | 2679 |
|
|
2017
Q1 | $207K | Buy |
4,913
+429
| +10% | +$18.1K | ﹤0.01% | 2482 |
|
|
2016
Q4 | $144K | Buy |
4,484
+1,590
| +55% | +$51.1K | ﹤0.01% | 2460 |
|
|
2016
Q3 | $76K | Buy |
2,894
+230
| +9% | +$6.04K | ﹤0.01% | 2556 |
|
|
2016
Q2 | $62K | Buy |
+2,664
| New | +$62K | ﹤0.01% | 2516 |
|
|
2015
Q4 | – | Sell |
-40
| Closed | -$1K | – | 4025 |
|
|
2015
Q3 | $1K | Sell |
40
-110
| -73% | -$2.75K | ﹤0.01% | 3853 |
|
|
2015
Q2 | $3K | Buy |
150
+38
| +34% | +$760 | ﹤0.01% | 3850 |
|
|
2015
Q1 | $1K | Sell |
112
-94
| -46% | -$839 | ﹤0.01% | 4020 |
|
|
2014
Q4 | $2K | Buy |
+206
| New | +$2K | ﹤0.01% | 4043 |
|